Zobrazeno 1 - 10
of 655
pro vyhledávání: '"P. Sevelda"'
Autor:
Michael Bonelli, Karolina Dalwigk, Alexander Platzer, Isabel Olmos Calvo, Silvia Hayer, Birgit Niederreiter, Johannes Holinka, Florian Sevelda, Thomas Pap, Günter Steiner, Giulio Superti-Furga, Josef S. Smolen, Hans P. Kiener, Thomas Karonitsch
Publikováno v:
Experimental and Molecular Medicine, Vol 51, Iss 7, Pp 1-11 (2019)
IRF-1: a key regulator in rheumatoid Arthritis Thomas Karonitsch at the Medical University of Vienna, Austria, and colleagues showed that activation of the protein interferon regulatory factor 1 (IRF-1) in human synoviocytes promoted the expression o
Externí odkaz:
https://doaj.org/article/0556bd95549c4104b07bf7eac69e3b46
Publikováno v:
Journal of the American Chemical Society; 1/17/2024, Vol. 146 Issue 2, p1603-1611, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lukas A Holzer, Florian Sevelda, Georg Fraberger, Olivia Bluder, Wolfgang Kickinger, Gerold Holzer
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92943 (2014)
BACKGROUND: Limb amputation is often an inevitable procedure in the advanced condition of various diseases and poses a dramatic impact on a patient's life. The aim of the present study is to analyze the impact of lower-limb amputations on aesthetic f
Externí odkaz:
https://doaj.org/article/171c7b3acb5c47509f4edb43d0627bf2
Publikováno v:
Geburtshilfe und Frauenheilkunde.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a50c87eef08c3df763e558aeeebff94f
https://doi.org/10.1055/s-0040-1713230
https://doi.org/10.1055/s-0040-1713230
Publikováno v:
Geburtshilfe und Frauenheilkunde.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d0405b80b163cfc1fcde42174db900a
https://doi.org/10.1055/s-0040-1713229
https://doi.org/10.1055/s-0040-1713229
Autor:
M. Gnant, Christoph Tinchon, M. Rudas, A Pichler, Marija Balic, Viktor Wette, M-Km Tea, Herbert Stöger, Edgar Petru, Richard Greil, M Hubalek, P Dubsky, Daniel Egle, G Pfeiler, Christian F. Singer, R. Bartsch, P. Sevelda, A. Petzer, S Bago-Horvath, S Frantal
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 14:A1-A53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd406f681b24461028d5be99496e8d2f
https://doi.org/10.1055/s-0037-1602559
https://doi.org/10.1055/s-0037-1602559
Autor:
Rupert Bartsch, Richard Greil, P. Sevelda, Georg Pfeiler, G Michael, Daniel Egle, Marija Balic, A Pichler, Zsuzsanna Bago-Horvath, Michael Hubalek, M-Km Tea, Viktor Wette, Edgar Petru, Christian F. Singer, Andreas L. Petzer, Margarethe Rudas, Christoph Tinchon, Herbert Stoeger, P Dubsky, S Frantal
Publikováno v:
Cancer Research. 77:P6-10
Background: Immune-based therapeutic strategies represent a promising approach in early and advanced breast cancer treatment. MUC1 glycoprotein is overexpressed and aberrantly glycosylated in over 90% of malignant breast cancer. It is involved in onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::265f0f0227612636637f288c030fb3c0
https://doi.org/10.1158/1538-7445.sabcs16-p6-10-01
https://doi.org/10.1158/1538-7445.sabcs16-p6-10-01
Autor:
Hiroaki Kobayashi, Claire Cropet, Ahmed El-Balat, Giovanni Scambia, Nuria Lainez, C. Pisano, I.L. Ray-Coquard, N. Raban, Mansoor Raza Mirza, Beyhan Ataseven, Frank Priou, Alexander Burges, C. Guillemet, P. Sevelda, Paul Buderath, Peter Vuylsteke, Justine Gantzer, R. Sverdlin, Nicoletta Colombo, Ana Herrero
Publikováno v:
Annals of Oncology. 31:S614
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::381c8e305926876b621a57db01e42322
https://doi.org/10.1016/j.annonc.2020.08.951
https://doi.org/10.1016/j.annonc.2020.08.951
Autor:
Locker Gottfried J, Altorjai Gabriela, Koestler Wolfgang, Sevelda Ursula, Pluschnig Ursula, Hussian Dagmar, Wenzel Catharina, Bartsch Rupert, Mader Robert, Zielinski Christoph C, Steger Guenther G
Publikováno v:
BMC Cancer, Vol 6, Iss 1, p 63 (2006)
Abstract Background Combining trastuzumab and chemotherapy is standard in her2/neu overexpressing advanced breast cancer. It is not established however, whether trastuzumab treatment should continue after the failure of one earlier combination. In th
Externí odkaz:
https://doaj.org/article/efdd5ff1172d4385b086646ed395fcfe